Severe-COVID-19 and mortality among patients (pts) with prostate cancer (PCa) receiving androgen deprivation therapy (ADT). Tucker, M. D., Schmidt, A., Hsu, C., Shyr, Y., Armstrong, A. J., Bakouny, Z., Chapman, C., Dawsey, S., Gartrell, B., Halabi, S., Joshi, M., Khaki, A., Menon, H., Puc, M., Sharifi, N., Shaya, J., Wulff-Burchfield, E., Zhang, T., Gupta, S., McKay, R. R., CCC19 Prostate Canc Working Grp LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.6_suppl.39

View details for Web of Science ID 000636801500090